Finnrick, an independent testing programme, publishes 4 assays for Biochem API: 2 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 4 Aug 2026.
Biochem API listed by Finnrick as "Trading", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/biochemapi.
Listed in the Finnrick vendor directory. Not yet tested.
Biochem API is listed as active. Tracked by Finnrick. No test data available yet.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 4 | 2 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
These details were read from Biochem API's own website on 2026-08-10. Pages consulted:
Biochem API is listed as active and we hold 4 Finnrick assays (2 passing, 2 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 4 assays for Biochem API: 2 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 4 Aug 2026.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: BiochemAPI Peptides Review, Biohacker Direct Peptides Review, BioInfinity Lab Peptides Review.